Triptorelin embonate, triptorelin pamoate    (DrugBank: Triptorelin)

1 disease
告示番号疾患名(ページ内リンク)臨床試験数
76下垂体性ゴナドトロピン分泌亢進症1

76. 下垂体性ゴナドトロピン分泌亢進症 [臨床試験数:25,薬物数:41(DrugBank:11),標的遺伝子数:3,標的パスウェイ数:10
Searched query = "Pituitary gonadotropin secretion hyperthyroidism", "Gonadotropin secreting pituitary adenoma", "Central precocious puberty", "Gonadotropin producing pituitary adenoma"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 25 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2015-001607-30-Outside-EU/EEA
(EUCTR)
24/04/2015Triptorelin 6-month formulation for children who mature too early because of a brain hormoneAn open-label, non-comparative, multicenter study on the efficacy, safety, and pharmacokinetics of triptorelin pamoate (embonate) 22.5 mg 6-month formulation in patients suffering from central (gonadotropin-dependent) precocious puberty - Triptorelin 6-month Formulation in Patients With Central Precocious Puberty Central Precocious Puberty
MedDRA version: 18.0;Level: PT;Classification code 10058084;Term: Precocious puberty;System Organ Class: 10014698 - Endocrine disorders;Therapeutic area: Body processes [G] - Biological Phenomena [G16]
INN or Proposed INN: TRIPTORELIN
Other descriptive name: Triptorelin embonate, Triptorelin pamoate
Debiopharm International, S.A.NULLNAFemale: yes
Male: yes
44United States;Chile;Mexico